These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8956461

  • 1. Effect of thyrotropin-releasing hormone (TRH) on cerebral blood flow in spinocerebellar degeneration and cerebrovascular disease.
    Izumi Y, Fukuuchi Y, Ishihara N, Imai A, Komatsumoto S.
    Tokai J Exp Clin Med; 1995 Dec; 20(4-6):203-8. PubMed ID: 8956461
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy of TRH-T for spinocerebellar degeneration--the relation between clinical features and effect of TRH therapy].
    Waragai M, Ogawara K, Takaya Y, Hayashi M.
    Rinsho Shinkeigaku; 1997 Jul; 37(7):587-94. PubMed ID: 9396355
    [Abstract] [Full Text] [Related]

  • 3. [Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects].
    Filla A, De Michele G, Di Martino L, Mengano A, Iorio L, Maggio MA, Campanella G.
    Riv Neurol; 1989 Jul; 59(2):83-8. PubMed ID: 2505370
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the effect of thyrotropin releasing hormone (TRH) on regional cerebral blood flow in spinocerebellar degeneration using 3DSRT.
    Kimura N, Kumamoto T, Masuda T, Nomura Y, Hanaoka T, Hazama Y, Okazaki T, Arakawa R.
    J Neurol Sci; 2009 Jun 15; 281(1-2):93-8. PubMed ID: 19286195
    [Abstract] [Full Text] [Related]

  • 5. The long loop reflex in spinocerebellar degeneration and motor neuron disease--its changes with TRH therapy.
    Touge T, Takeuchi H, Yamada A, Miki H, Nishioka M.
    Electromyogr Clin Neurophysiol; 1990 Jun 15; 30(3):131-40. PubMed ID: 2112456
    [Abstract] [Full Text] [Related]

  • 6. Effect of central thyrotropin-releasing hormone on pancreatic blood flow in rats.
    Goto M, Yoneda M, Nakamura K, Terano A, Haneda M.
    Regul Pept; 2004 Sep 15; 121(1-3):57-63. PubMed ID: 15256274
    [Abstract] [Full Text] [Related]

  • 7. Thyrotropin-releasing hormone (TRH) causes sympathetic activation and cerebral vasodilation in the rabbit.
    Koskinen LO, Bill A.
    Acta Physiol Scand; 1984 Oct 15; 122(2):127-36. PubMed ID: 6097095
    [Abstract] [Full Text] [Related]

  • 8. [Spinocerebellar degeneration and neuropeptides].
    Matsuoka Y, Sakurai N.
    Nihon Naika Gakkai Zasshi; 1989 Dec 15; 78(12):1705-8. PubMed ID: 2516527
    [No Abstract] [Full Text] [Related]

  • 9. Effect of pentoxifylline on regional cerebral blood flow in patients with cerebrovascular disease.
    Hartmann A.
    Pharmatherapeutica; 1981 Dec 15; 2(8):528-31. PubMed ID: 7255509
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of thyrotropin-releasing hormone on cerebral blood flow in conscious rat.
    Kondoh Y, Mizusawa S, Murakami M, Nagata K, Sasaki H, Nakamichi H, Watanabe K, Uemura K.
    J Cereb Blood Flow Metab; 1989 Apr 15; 9(2):196-203. PubMed ID: 2493461
    [Abstract] [Full Text] [Related]

  • 12. [Tolerance of long-term protirelin tartrate treatment].
    Caraccio N, Monzani F, Casolaro A, Pucci E, Luisi M, Franchi F.
    Recenti Prog Med; 1995 Jun 15; 86(6):226-30. PubMed ID: 7624581
    [Abstract] [Full Text] [Related]

  • 13. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
    Rajput SK, Krishnamoorthy S, Pawar C, Kaur N, Monga V, Meena CL, Jain R, Sharma SS.
    Epilepsy Behav; 2009 Jan 15; 14(1):48-53. PubMed ID: 18952198
    [Abstract] [Full Text] [Related]

  • 14. Thyrotropin-releasing hormone in the dorsal vagal complex stimulates pancreatic blood flow in rats.
    Yoneda M, Goto M, Nakamura K, Yokohama S, Kono T, Tanamo M, Shimada T, Hiraishi H.
    Regul Pept; 2005 Nov 15; 131(1-3):74-81. PubMed ID: 16040141
    [Abstract] [Full Text] [Related]

  • 15. Cerebral blood flow in patients with chronic cerebrovascular disease: effect of acetyl L-carnitine.
    Postiglione A, Cicerano U, Soricelli A, De Chiara S, Gallotta G, Salvatore M, Mancini M.
    Int J Clin Pharmacol Res; 1990 Nov 15; 10(1-2):129-32. PubMed ID: 2387659
    [Abstract] [Full Text] [Related]

  • 16. Effects of TRH on cerebral and peripheral blood flows; role of submesencephalic brain stem centres.
    Koskinen LO.
    Acta Physiol Scand; 1986 Oct 15; 128(2):277-88. PubMed ID: 3096078
    [Abstract] [Full Text] [Related]

  • 17. [Alteration of CBF and CMRO2 and TRH effects on CBF in spinocerebellar degeneration. The positron emission tomography study].
    Harada K, Fukuyama H, Miyoshi T, Namura Y, Kameyama M.
    Rinsho Shinkeigaku; 1988 May 15; 28(5):563-8. PubMed ID: 3145826
    [No Abstract] [Full Text] [Related]

  • 18. PET study in a patient with spinocerebellar degeneration before and after long-term administration of thyrotropin releasing hormone.
    Tanji H, Nagasawa H, Hayashi T, Onodera H, Fujiwara T, Itoh M, Ido T, Itoyama Y.
    Behav Neurol; 1996 May 15; 9(3):171-5. PubMed ID: 24487517
    [Abstract] [Full Text] [Related]

  • 19. Clinical manifestations and thyrotropin releasing hormone therapy in cerebellar degenerations.
    Wang HC, Chiu HC.
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Mar 15; 47(3):161-8. PubMed ID: 1848143
    [Abstract] [Full Text] [Related]

  • 20. Intravenous thyrotropin releasing hormone in amyotrophic lateral sclerosis: autonomic effects.
    Beaulieu DA, Erickson L, Williams A, Sufit RL, Brooks BR.
    Neurol Clin; 1987 May 15; 5(2):269-90, vi. PubMed ID: 11681403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.